Factors associated with untreated hypertension among older adults: Results of the Mexican Health and Aging Study, 2001;Factores asociados con la hipertensión no tratada en los adultos mayores: Resultados del Estudio Nacional sobre Salud y Envejecimiento en México, 2001

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 23, Issue 5, 2008, Pages 295-302

  Melano Carranza, Efrén ^a   Ojeda, Luis Alberto Lasses ^a   Ávila Funes, José Alberto ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Aged; Hypertension control; Mexico; Patient compliance

Indexed keywords

ADULT; AGING; BODY MASS; DISEASE CONTROL; DISEASE TREATMENT; HEALTH CARE; HYPERTENSION;

MEXICO [NORTH AMERICA]; NORTH AMERICA;

EID: 46749156705     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/s1020-49892008000500001     Document Type: Article

References (36)

1. Estados Unidos Mexicanos, Secretaría de Salud. Estadísticas de egresos hospitalarios del sector público del Sistema Nacional de Salud, 2001. Salud Publica Mex. 2003;45:310-27.
2. Instituto Nacional de Estadística, Geografíae Informática. Los adultos mayores en México. Perfil sociodemográfico al inicio del siglo XXI [sitio en Internet]. México: INEGI; 2005. Hallado en: http://www.inegi.gob.mx/prod_serv/ contenidos/espanol/bvinegi/productos/censos/poblacion/adultosmayores/ Adultos_mayores_web2.pdf. Acceso el 29 de enero de 2008.
3. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-16.
4. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. J Am Med Assoc. 2002;287:1003-10.
5. Velázquez MO, Rosas PM, Lara EA, Pastelín HG. Hipertensión arterial en México: resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex. 2002;72:71-84.
6. Fields LE, Burt VL, Cutler JA, Hugher J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44;398-404.
7. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101:825-36.
8. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-86.
9. Senst BL, Achusim LE, Genest RP, Cosentino LA, Ford CC, Little JA, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm. 2001;58:1126-32.
10. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a metaanalysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-13.
11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 353:487-97.
12. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;39:1957-63.
13. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-20.
14. Estudio Nacional sobre Salud y Envejecimiento en México (ENASEM) [sitio en Internet]. México, D.F.: Universidad de Pennsylvania. Hallado en: http://www.ssc.upenn.edu/mhas/. Acceso el 29 de enero de 2008.
15. Instituto Nacional de Estadística, Geografía e Informática. II Conteo de Población y Vivienda [sitio en Internet], México, D.F.: INEGI; 2005. Hallado en: http://www.megi.gob.mx/ est/contenidos/espanol/sistemas/conteo2005/datos/00/excel/cpv00_viv_11.xis. Acceso el 28 de febrero de 2008.
16. Aguilar-Navarro SG, Fuentes-Cantú A, Ávila-Funes JA, García-Mayo EJ. Validity and reliability of the screening questionnaire for geriatric depression used in the Mexican Health and Age Study. Salud Publica Mex. 2007;49:256-62.
17. Glosser G, Wolfe N, Albert ML, Lavini L, Steele JC, Calne DB, et al. Cross-cultural cognitive examination: validation of a dementia screening instrument for neuroepidemiological research. J Am Geriatr Soc. 1993;41:931-9.
18. Katz S, Akpom CA. 12 Index of ADL. Med Care. 1976;14:116-8.
19. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-86.
20. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92-106.
21. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. J Am Med Assoc. 2003;289:2560-72.
22. Burnier M. Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension. Blood Press Monit. 2000;5:S31-4.
23. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;2:CD000011.
24. Balkrishnan R. Predictors of medication adherence in the elderlv. Clin Ther. 1998;20:764-71.
25. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085-90.
26. Stilley CS, Sereika S, Muldoon MF, Ryan CM, Dunbar-Jacob J. Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Ann Behav Med. 2004;27:117-24.
27. Lerman I. Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res. 2005;36:300-6.
28. a ed. México, D.F.: Manual Moderno; 2006. Pp. 273-9.
29. Fincke BG, Miller DR, Spiro A 3rd. The interaction of patient perception of overmedication with drug compliance and side effects. J Gen Intern Med. 1998;13:182-5.
30. Piette JD, Richardson C, Valenstein M. Addressing the needs of patients with multiple chronic illnesses: the case of diabetes and depression. Am J Manag Care. 2004;10:152-62.
31. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM. Adherence to statins, beta-blockers and angiotensinconverting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol. 2005;21:485-8.
32. Feldman R, Bacher M, Campbell N, Drover A, Chockalingam A. Adherence to pharmacologic management of hypertension. Can J Public Health. 1998;89:116-8.
33. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2:757-64.
34. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-4.
35. Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol. 1997;13:914-20.
36. Borzecki AM, Oliveria SA, Berlowitz DR. Barriers to hypertension control. Am Heart J. 2005;149:785-94.